BR0010248A - 1-(p-tienilbenzil)-imidazóis como agonistas de receptores de angiotensina-(1-7), processo para a sua preparação, seu uso e preparados farmacêuticos contendo os mesmos - Google Patents
1-(p-tienilbenzil)-imidazóis como agonistas de receptores de angiotensina-(1-7), processo para a sua preparação, seu uso e preparados farmacêuticos contendo os mesmosInfo
- Publication number
- BR0010248A BR0010248A BR0010248-2A BR0010248A BR0010248A BR 0010248 A BR0010248 A BR 0010248A BR 0010248 A BR0010248 A BR 0010248A BR 0010248 A BR0010248 A BR 0010248A
- Authority
- BR
- Brazil
- Prior art keywords
- imidazoles
- receptor agonists
- preparation
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- BKMHLMJNCPWYLO-UHFFFAOYSA-N 1-[(4-thiophen-2-ylphenyl)methyl]imidazole Chemical class C1=CN=CN1CC(C=C1)=CC=C1C1=CC=CS1 BKMHLMJNCPWYLO-UHFFFAOYSA-N 0.000 title abstract 2
- 102000008873 Angiotensin II receptor Human genes 0.000 title abstract 2
- 108050000824 Angiotensin II receptor Proteins 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 4
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010003178 Arterial thrombosis Diseases 0.000 abstract 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 abstract 1
- 208000006029 Cardiomegaly Diseases 0.000 abstract 1
- 208000031229 Cardiomyopathies Diseases 0.000 abstract 1
- 206010048554 Endothelial dysfunction Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- PVHLMTREZMEJCG-GDTLVBQBSA-N Ile(5)-angiotensin II (1-7) Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 PVHLMTREZMEJCG-GDTLVBQBSA-N 0.000 abstract 1
- 206010061216 Infarction Diseases 0.000 abstract 1
- 206010047249 Venous thrombosis Diseases 0.000 abstract 1
- 238000002399 angioplasty Methods 0.000 abstract 1
- 108010021281 angiotensin I (1-7) Proteins 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 230000003293 cardioprotective effect Effects 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 230000008694 endothelial dysfunction Effects 0.000 abstract 1
- 230000009843 endothelial lesion Effects 0.000 abstract 1
- 230000007574 infarction Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
- 230000000304 vasodilatating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Patente de Invenção: "1-(p-TIENILBENZIL)-IMIDAZóIS COMO AGONISTAS DE RECEPTORES DE ANGIOTENSINA-(1-7), PROCESSO PARA A SUA PREPARAçãO, SEU USO E PREPARADOS FARMACêUTICOS CONTENDO OS MESMOS". A invenção refere-se a novos 1-(p-tiofenilbenzil)-imidazóis da fórmula (1), na qual os radicais R(1) - R(6), X e Y possuem os significados dados na descrição. Tais compostos são potentes agonistas de receptores de angiotensina-(1-7). Como resultado da produção e liberação de substâncias mensageiras vasodilatadoras, antitrombóticas e cardio-protetoras tais como monofosfato de 3',5'-guanosina cíclico (CGMP) e monóxido de nitrogênio (NO), relacionados com a estimulação desses receptores em células endoteliais, tais compostos representam valiosos medicamentos para o tratamento e profilaxia de hipertensão, hipertrofia cardíaca, insuficiência cardíaca, doenças cardíacas coronarianas tal como a Angina pectoris, infarto cardíaco, restenose vascular após angioplastia, cardiomiopatias, uma disfunção endotelial ou lesões endoteliais, por exemplo como conseq³ência de processos aterioscleróticos ou em caso de Diabetis mellitus e de tromboses arteriais ou venosas.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1999120815 DE19920815A1 (de) | 1999-05-05 | 1999-05-05 | 1-(p-Thienylbenzyl)-Imidazole als Agonisten von Angiotensin-(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| DE1999161686 DE19961686A1 (de) | 1999-12-21 | 1999-12-21 | 1-(p-Thienylbenzyl)-Imidazole als Agonisten von Angiotensin-1(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| PCT/EP2000/003891 WO2000068226A1 (de) | 1999-05-05 | 2000-04-29 | 1-(p-thienylbenzyl)-imidazole als agonisten von angiotensin-(1-7)-rezeptoren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0010248A true BR0010248A (pt) | 2002-02-13 |
Family
ID=26053245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0010248-2A BR0010248A (pt) | 1999-05-05 | 2000-04-29 | 1-(p-tienilbenzil)-imidazóis como agonistas de receptores de angiotensina-(1-7), processo para a sua preparação, seu uso e preparados farmacêuticos contendo os mesmos |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US6235766B1 (pt) |
| EP (1) | EP1185527B1 (pt) |
| JP (1) | JP2002544130A (pt) |
| KR (1) | KR20020012207A (pt) |
| CN (1) | CN1158279C (pt) |
| AR (1) | AR023837A1 (pt) |
| AT (1) | ATE300535T1 (pt) |
| AU (1) | AU775244B2 (pt) |
| BR (1) | BR0010248A (pt) |
| CA (1) | CA2373010A1 (pt) |
| CZ (1) | CZ20013907A3 (pt) |
| DE (1) | DE50010835D1 (pt) |
| EE (1) | EE200100572A (pt) |
| HK (1) | HK1045519B (pt) |
| HR (1) | HRP20010814A2 (pt) |
| HU (1) | HUP0201311A3 (pt) |
| IL (1) | IL146198A0 (pt) |
| NO (1) | NO20015309L (pt) |
| NZ (1) | NZ515242A (pt) |
| PL (1) | PL351609A1 (pt) |
| RU (1) | RU2247121C2 (pt) |
| SK (1) | SK15942001A3 (pt) |
| TR (1) | TR200103171T2 (pt) |
| WO (1) | WO2000068226A1 (pt) |
| YU (1) | YU78601A (pt) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6630498B2 (en) * | 1997-08-06 | 2003-10-07 | Smithkline Beecham Corporation | Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation |
| US6329159B1 (en) * | 1999-03-11 | 2001-12-11 | Millennium Pharmaceuticals, Inc. | Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function |
| DE10112041A1 (de) * | 2001-03-14 | 2002-09-26 | Aventis Pharma Gmbh | p-Thienylbenzyl-Amide als Agonisten von Angiotensin-(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| AU2002257970B2 (en) | 2001-05-31 | 2007-08-02 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin II agonists |
| JP4707321B2 (ja) * | 2001-05-31 | 2011-06-22 | ヴィコール・ファルマ・アーベー | アンギオテンシンｉｉアゴニストとして有用な三環式化合物 |
| US6610726B2 (en) * | 2001-06-29 | 2003-08-26 | North Shore-Long Island Jewish Research Institute | Compositions and agents for modulating cellular proliferation and angiogenesis |
| JP2005508358A (ja) * | 2001-10-25 | 2005-03-31 | デポメド・インコーポレイテッド | 胃滞留型ロサルタン投与量を用いる治療方法 |
| WO2003072059A2 (en) * | 2002-02-27 | 2003-09-04 | Wake Forest University | Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
| EP1348440A1 (en) * | 2002-03-28 | 2003-10-01 | Citeq B.V. | Use of angiotensin 1-7 for enhancing cardiac function |
| NL1021048C2 (nl) | 2002-07-11 | 2004-01-13 | Weir Netherlands B V | Zuigermembraanpomp. |
| WO2004046137A1 (en) * | 2002-11-21 | 2004-06-03 | Vicore Pharma Ab | New tricyclic angiotensin ii agonists |
| AU2003302106A1 (en) * | 2002-11-21 | 2004-06-15 | Vicore Pharma Ab | New tricyclic angiotensin ii agonists |
| WO2004085420A1 (en) * | 2003-03-24 | 2004-10-07 | Vicore Pharma Ab | Bicyclic compounds useful as angiotensin ii agonists |
| US7176261B2 (en) | 2004-10-21 | 2007-02-13 | Medtronic, Inc. | Angiotensin-(1-7) eluting polymer-coated medical device to reduce restenosis and improve endothelial cell function |
| ES2395194T3 (es) * | 2005-04-12 | 2013-02-11 | Vicore Pharma Ab | Nuevos agonistas tricíclicos de la angiotensina II |
| BRPI0502497A (pt) * | 2005-06-28 | 2007-02-06 | Univ Minas Gerais | uso de agonistas e antagonistas do receptor acoplado a proteìna g, mas, como moduladores de atividade apoptótica para o estudo, a prevenção e o tratamento de doenças |
| BRPI0602366B1 (pt) * | 2006-04-26 | 2017-12-12 | Universidade Federal De Minas Gerais | Use of agonists of the receptor coupled to protein g, but, in the treatment of metabolic syndrome, its components and their complications |
| WO2008052179A2 (en) * | 2006-10-27 | 2008-05-02 | Medtronic, Inc. | Angiotensin (1-7) eluting stent |
| KR100885197B1 (ko) * | 2008-09-25 | 2009-02-24 | 박창수 | 다면다각형상 구현이 용이한 엘이디조명 램프용 인쇄회로기판 |
| EP2163259B1 (en) | 2008-09-12 | 2012-06-13 | Charité-Universitätsmedizin Berlin (Charité) | Use of an Ang-(1-7) receptor agonist in acute lung injury |
| WO2013090833A1 (en) * | 2011-12-16 | 2013-06-20 | Tarix Pharmaceuticals Ltd. | Angiotensins for treatment of fibrosis |
| AU2013216910A1 (en) * | 2012-02-10 | 2014-08-28 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of peripheral vascular disease |
| US8557958B1 (en) * | 2012-06-18 | 2013-10-15 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of diabetes |
| US8633158B1 (en) | 2012-10-02 | 2014-01-21 | Tarix Pharmaceuticals Ltd. | Angiotensin in treating brain conditions |
| MX2015014668A (es) * | 2013-04-19 | 2016-06-30 | Univ Iowa Res Found | Angiotensinas en la distrofia muscular. |
| CN105451756A (zh) | 2013-05-24 | 2016-03-30 | 塔瑞克斯制药有限公司 | 在治疗马凡氏综合征及其相关病症中的血管紧张素肽 |
| US9333233B2 (en) | 2014-02-25 | 2016-05-10 | Tarix Pharmaceuticals Ltd. | Methods and compositions for the delayed treatment of stroke |
| KR102697698B1 (ko) | 2014-07-17 | 2024-08-21 | 유니버시티 오브 써던 캘리포니아 | 근골격 질환들의 치료를 위한 방법들, 화합물들 및 조성물들 |
| US10960045B2 (en) | 2015-10-14 | 2021-03-30 | Constant Therapeutics Llc | Methods and compositions for the treatment of epidermolysis bullosa |
| KR102538999B1 (ko) | 2016-06-29 | 2023-05-31 | 유니버시떼 드 몬트리얼 | 비아릴메틸 헤테로사이클 |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
| GB201913603D0 (en) * | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| EP4117703A1 (en) | 2020-03-13 | 2023-01-18 | Constant Therapeutics LLC | Methods and compositions for treatment of coronavirus infection |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5140037A (en) * | 1990-03-20 | 1992-08-18 | E. I. Du Pont De Nemours And Company | Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists |
| CA2058198A1 (en) * | 1991-01-04 | 1992-07-05 | Adalbert Wagner | Azole derivatives, process for their preparation, and their use |
| US5177074A (en) | 1991-03-26 | 1993-01-05 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| US5252574A (en) | 1991-04-26 | 1993-10-12 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a substituted thiophene or furan |
| US5198438A (en) * | 1991-05-07 | 1993-03-30 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| US5256667A (en) | 1991-09-25 | 1993-10-26 | Merck & Co., Inc. | Quinazolinones and pyridopyrimidinones |
| WO1994027597A1 (en) * | 1993-05-21 | 1994-12-08 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acid angiotensin ii receptor antagonists |
| US5444067A (en) | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| FR2716882B1 (fr) * | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
-
2000
- 2000-04-20 YU YU78601A patent/YU78601A/sh unknown
- 2000-04-29 EP EP00929466A patent/EP1185527B1/de not_active Expired - Lifetime
- 2000-04-29 KR KR1020017014082A patent/KR20020012207A/ko not_active Application Discontinuation
- 2000-04-29 IL IL14619800A patent/IL146198A0/xx unknown
- 2000-04-29 CZ CZ20013907A patent/CZ20013907A3/cs unknown
- 2000-04-29 TR TR2001/03171T patent/TR200103171T2/xx unknown
- 2000-04-29 JP JP2000616200A patent/JP2002544130A/ja active Pending
- 2000-04-29 AT AT00929466T patent/ATE300535T1/de not_active IP Right Cessation
- 2000-04-29 WO PCT/EP2000/003891 patent/WO2000068226A1/de not_active Application Discontinuation
- 2000-04-29 CA CA002373010A patent/CA2373010A1/en not_active Abandoned
- 2000-04-29 EE EEP200100572A patent/EE200100572A/xx unknown
- 2000-04-29 DE DE50010835T patent/DE50010835D1/de not_active Expired - Lifetime
- 2000-04-29 PL PL00351609A patent/PL351609A1/xx not_active Application Discontinuation
- 2000-04-29 RU RU2001132724/04A patent/RU2247121C2/ru not_active IP Right Cessation
- 2000-04-29 AU AU47536/00A patent/AU775244B2/en not_active Ceased
- 2000-04-29 NZ NZ515242A patent/NZ515242A/en unknown
- 2000-04-29 HU HU0201311A patent/HUP0201311A3/hu unknown
- 2000-04-29 CN CNB008067996A patent/CN1158279C/zh not_active Expired - Fee Related
- 2000-04-29 SK SK1594-2001A patent/SK15942001A3/sk unknown
- 2000-04-29 BR BR0010248-2A patent/BR0010248A/pt not_active IP Right Cessation
- 2000-05-03 AR ARP000102117A patent/AR023837A1/es unknown
- 2000-05-04 US US09/564,544 patent/US6235766B1/en not_active Expired - Lifetime
-
2001
- 2001-03-16 US US09/809,008 patent/US6429222B2/en not_active Expired - Lifetime
- 2001-10-30 NO NO20015309A patent/NO20015309L/no not_active Application Discontinuation
- 2001-11-05 HR HR20010814A patent/HRP20010814A2/hr not_active Application Discontinuation
- 2001-12-13 US US10/013,459 patent/US20020077344A1/en not_active Abandoned
-
2002
- 2002-09-26 HK HK02107057.3A patent/HK1045519B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20010814A2 (en) | 2003-02-28 |
| HUP0201311A3 (en) | 2003-03-28 |
| AR023837A1 (es) | 2002-09-04 |
| WO2000068226A1 (de) | 2000-11-16 |
| EP1185527A1 (de) | 2002-03-13 |
| HK1045519A1 (en) | 2002-11-29 |
| KR20020012207A (ko) | 2002-02-15 |
| IL146198A0 (en) | 2002-07-25 |
| US20010018449A1 (en) | 2001-08-30 |
| ATE300535T1 (de) | 2005-08-15 |
| US6235766B1 (en) | 2001-05-22 |
| RU2247121C2 (ru) | 2005-02-27 |
| HK1045519B (zh) | 2005-04-22 |
| JP2002544130A (ja) | 2002-12-24 |
| TR200103171T2 (tr) | 2002-06-21 |
| US20020077344A1 (en) | 2002-06-20 |
| AU775244B2 (en) | 2004-07-22 |
| EE200100572A (et) | 2003-02-17 |
| NO20015309D0 (no) | 2001-10-30 |
| AU4753600A (en) | 2000-11-21 |
| DE50010835D1 (de) | 2005-09-01 |
| CN1349530A (zh) | 2002-05-15 |
| NZ515242A (en) | 2003-11-28 |
| US6429222B2 (en) | 2002-08-06 |
| HUP0201311A2 (en) | 2002-10-28 |
| YU78601A (sh) | 2005-07-19 |
| PL351609A1 (en) | 2003-05-05 |
| CN1158279C (zh) | 2004-07-21 |
| SK15942001A3 (sk) | 2002-04-04 |
| NO20015309L (no) | 2001-12-28 |
| CZ20013907A3 (cs) | 2002-02-13 |
| EP1185527B1 (de) | 2005-07-27 |
| CA2373010A1 (en) | 2000-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0010248A (pt) | 1-(p-tienilbenzil)-imidazóis como agonistas de receptores de angiotensina-(1-7), processo para a sua preparação, seu uso e preparados farmacêuticos contendo os mesmos | |
| MY134696A (en) | Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them | |
| DE69627035D1 (de) | Derivate von aminosäuren, sie enthaltende pharmazeutische zusammensetzungen sowie deren herstellunsgverfahren | |
| NO940261L (no) | 5-leddete heterocykler, fremgangsmåte ved fremstilling derav og legemidler som inneholder disse forbindelser | |
| NO933248L (no) | Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
| ATE360622T1 (de) | Substituierte 2-aryl-4-amino-chinazoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| BR0111230A (pt) | Composto, e, uso e processo para a preparação do mesmo | |
| PT1131302E (pt) | 4-amino-2-aril-ciclopenta[d]pirimidinas substituidas, sua preparacao, sua utilizacao e preparacoes farmaceuticas que as contem | |
| PL308673A1 (en) | Dithiocarbaminates for pharmacological tratment of arterial atherosclerosis and other cardiovascular and inflammatory diseases | |
| EP1695961A1 (en) | Urea derivative, process for producing the same, and use | |
| CA2277949A1 (en) | Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions | |
| ATE147074T1 (de) | Verbindungen welche antihypertensive und antiischemische eigenschaften besitzen | |
| WO2000008014A8 (de) | Disubstituierte bicyclische heterocyclen mit insbesondere einer thrombinhemmenden wirkung | |
| BR9713552A (pt) | Derivados de pirimidina bicìclicos condensados | |
| CA2340405A1 (en) | Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same | |
| RS104804A (en) | N-((3-oxo 2,3-dihydro-1h-isoindol- 1yl)acetyl)guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris | |
| KR19990014816A (ko) | 항-혈소판 응집억제제와 혈관확장제로서 유용한 아미딘 유도체 | |
| AU2003274686A8 (en) | Inhibitors of the gpib -vwf interaction, their preparation and use | |
| BR9911942B1 (pt) | "n-arilamidas de ácido sulfonilaminocarboxílico como ativadores da ciclasse de guanilato e composições farmacêuticas contendo as mesmas" | |
| DK1150963T3 (da) | Substituerede 4-amino-2-aryltetrahydroquinazoliner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem | |
| NO20062740L (no) | Duale molekyler inneholdende peroksyderivat, syntese derav og terapeutiske anvendelser derav | |
| BG100954A (en) | Derivatives of hydrosamic acid, pharmaceutical compositions based on them and method for their preparation | |
| Iwama et al. | Discovery of a potent and selective αvβ3 integrin antagonist with strong inhibitory activity against neointima formation in rat balloon injury model | |
| TR200100083T2 (tr) | 2,5 İkameli benzol sülfonil ve tiyo üreler | |
| AU579196B2 (en) | 4-Oxo-piridol(2,3-d)pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A, 8A E 9A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009. |